133 related articles for article (PubMed ID: 34531687)
1. A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer.
Zhang D; Li Y; Li H; Tang T; Zheng Y; Guo X; Xu X
Cancer Manag Res; 2021; 13():7131-7137. PubMed ID: 34531687
[TBL] [Abstract][Full Text] [Related]
2. Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study.
Tang J; Fu Y; Song Y; Yin J; Wang J; Arasanz H; Zhang B
J Thorac Dis; 2024 May; 16(5):3251-3259. PubMed ID: 38883687
[TBL] [Abstract][Full Text] [Related]
3. Association between serum baseline C1q and IgG levels and the efficacy of combined immunotherapy in patients with esophageal squamous cell carcinoma: a retrospective study.
Wen J; Zhao Y; Fang CX; Wu XH
Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):83-88. PubMed ID: 35997274
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of circulating tumor cells in monitoring the efficacy of neoadjuvant immunotherapy for non-small cell lung cancer].
Li YJ; Chen H; Liao JF; Yuan JL; Chen T; Zhu J
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Feb; 55(2):233-238. PubMed ID: 34645185
[No Abstract] [Full Text] [Related]
6. [Changes of Serum Complement C1q in Patients with Multiple Myeloma].
Gui CS; Liu SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):506-510. PubMed ID: 35395987
[TBL] [Abstract][Full Text] [Related]
7. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
8. Serum C1q Levels Have Prognostic Value for Sepsis and are Related to the Severity of Sepsis and Organ Damage.
Li H; Chen J; Hu Y; Cai X; Tang D; Zhang P
J Inflamm Res; 2021; 14():4589-4600. PubMed ID: 34531674
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficacy analysis of immunotherapy in small cell lung cancer].
Zhong J; Zheng QW; Zhao J; Wang ZP; Wu MN; Zhuo ML; Wang YY; Li JJ; Yang X; Chen HX; An TT
Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):771-776. PubMed ID: 32988161
[No Abstract] [Full Text] [Related]
10. Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC.
Li B; Li C; Guo M; Shang S; Li X; Xie P; Sun X; Yu J; Wang L
Onco Targets Ther; 2018; 11():6287-6294. PubMed ID: 30310292
[TBL] [Abstract][Full Text] [Related]
11. The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease.
Jia Y; Wen W; Yang Y; Huang M; Ning Y; Jiao X; Liu S; Qin Y; Zhang M
Clin Biochem; 2021 Jul; 93():50-58. PubMed ID: 33861985
[TBL] [Abstract][Full Text] [Related]
12. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
13. Elevated Serum C1q Levels in Children With Sepsis.
Li H; Chen J; Hu Y; Cai X; Zhang P
Front Pediatr; 2021; 9():619899. PubMed ID: 33981650
[No Abstract] [Full Text] [Related]
14. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
15. Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer.
Huang W; Liu P; Zong M; Chen QQ; Zhou H; Kong H; Xie WP
Cancer Manag Res; 2021; 13():4299-4307. PubMed ID: 34103985
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
[TBL] [Abstract][Full Text] [Related]
17. Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
Papachristofilou A; Hipp MM; Klinkhardt U; Früh M; Sebastian M; Weiss C; Pless M; Cathomas R; Hilbe W; Pall G; Wehler T; Alt J; Bischoff H; Geißler M; Griesinger F; Kallen KJ; Fotin-Mleczek M; Schröder A; Scheel B; Muth A; Seibel T; Stosnach C; Doener F; Hong HS; Koch SD; Gnad-Vogt U; Zippelius A
J Immunother Cancer; 2019 Feb; 7(1):38. PubMed ID: 30736848
[TBL] [Abstract][Full Text] [Related]
18. Molecularly targeted therapy using bevacizumab for non-small cell lung cancer: a pilot study for the new CT response criteria.
Lee HY; Lee KS; Hwang HS; Lee JW; Ahn MJ; Park K; Kim TS; Yi CA; Chung MJ
Korean J Radiol; 2010; 11(6):618-26. PubMed ID: 21076587
[TBL] [Abstract][Full Text] [Related]
19. [Value of dual-energy CT-based volumetric iodine-uptake in the evaluation of chemotherapy efficacy in advanced gastric cancer].
Chen LF; Fu GZ; Huang DP; Man Y; Jin Y; Dong QT; Huang YB; Chen YC; Wang HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):977-983. PubMed ID: 31630497
[No Abstract] [Full Text] [Related]
20. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
